T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL). T-ALL, known for its challenging ...

"It raises the prospect of a 'one-size-fits-all' cancer treatment, a single type of T-cell that could be capable of destroying many different types of cancers across the population." T-cells have ...

gives a potentially effective treatment for patients with T-cell acute lymphoblastic leukemia (T-ALL) who have exhausted all standard treatment options. Published in the prestigious medical ...

TCRclub integrates scRNA-seq and scTCR-seq data by local harmony to identify functionally similar T cell groups, termed ...

The improvements persisted in all but one recipient, who showed slight reversals during a one-year observation period. Bharti ...

These sort of "living drugs"—T-cells modified to expand, recognize and attack cancer cells within the body—offer ... For children with acute lymphoblastic leukemia (ALL), measurable residual ...

"We found ASXL1 mutated in the T cells of all of those patients and decided to investigate further." "We showed Asxl1 disruption endows T cells with superior long-term therapeutic potential ...

I’ve tested smartphones and cell phone plans from all the major carriers—the historic foursome of AT&T, Sprint, T-Mobile, and Verizon, plus Nextel before then—for the Washington Post ...

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells ...

achieving a median T cell purity of 98.5%. All patients received a standard conditioning treatment of fludarabine and cyclophosphamide lymphodepletion before infusion with CART-123. Of the six ...

In the fight against antibiotic resistance, a new technology developed at Chalmers University of Technology, in Sweden, can be of great importance when, for example, hip and knee implants are ...